Product Categories
Country: | China |
---|---|
Tel: | 025-025-58741518 |
Mobile: | 18013010638 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
CarbaMic acid, N-[(1R,2S,5S)-2-aMino-5-[(diMethylaMino)carbonyl]cyclohexyl]-, 1,1-diMethylethyl ester | C14H27N3O3 | 365998-36-3 | Details |
AcetaMide, N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]- | C18H16N2O4S | 198471-06-6 | Details |
2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- | C19H24N4O3 | 289472-81-7 | Details |
PropanaMide, 2-Methyl-N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]- | C20H20N2O4S | 198470-82-5 | Details |
Acetic acid, 2-[(5-chloro-2-pyridinyl)aMino]-2-oxo-, ethyl ester, hydrochloride (1:1) | C9H10Cl2N2O3 | 1243308-37-3 | Details |
Boronic acid, B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]- | C19H25BN4O4 | 1132709-16-0 | Details |
2-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-(aMinocarbonyl)-, 1,1-diMethylethyl ester, (1S,3R,5S)- | C11H18N2O3 | 1564266-79-0 | Details |
BenzylhydroxylaMine hydrochloride | C7H10ClNO | 29601-98-7 | Details |
cis-5-Norbornene-exo-2,3-dicarboxylic anhydride | C9H8O3 | 2746-19-2 | Details |
2-(2,5-dichlorobenzamido)acetic acid | C9H7Cl2NO3 | 667403-46-5 | Details |
3-(N,N-DiMethylaMinoMethyl)-5-Methyl-2-hexanone | C10H21NO | 91342-74-4 | Details |
CarbaMicacid,N-[(3aS,4R,6S,6aR)-tetrahydro-6-hydroxy-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]-,phenylMethyl ester | C16H21NO5 | 274693-53-7 | Details |
BenzenesulfonaMide, 4-(5-Methyl-3-phenyl-4-isoxazolyl)-N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]- | C32H25N3O6S2 | 1373038-60-8 | Details |
Boronic acid, B-[(1S)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]- | C19H25BN4O4 | 1132709-14-8 | Details |
tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate | C16H29N3O7 | 1210348-34-7 | Details |
Acetic acid, 2-[(5-chloro-2-pyridinyl)aMino]-2-oxo-, ethyl ester | C9H9ClN2O3 | 349125-08-2 | Details |
BenzenesulfonaMide, 3-[4-[4-(aMinosulfonyl)phenyl]-5-Methyl-3-isoxazolyl]- | C16H15N3O5S2 | 1373038-59-5 | Details |
Lubiprostone IMpurity | Details |
(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate | C15H28N2O6S | 929693-31-2 | Details |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- | C18H25N3O2 | 1564265-93-5 | Details |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- | C18H25N3O2 | 1564266-03-0 | Details |
CIS-N-BENZYL-3-METHYLAMINO-4-METHYL-PIPERIDINE BIS-(HYDROCHLORIDE) | C14H23ClN2 | 1062580-52-2 | Details |
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-triMethyl-alpha-(2-Methylpropyl)-4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine 2,2,2-trifluoroacetate | C17H29BF3NO4 | 179324-87-9 | Details |
edoxaban | C24H30ClN7O4S | 480449-70-5 | Details |
(1S,3S,5S)-3-(AMinocarbonyl)-2-azabicyclo[3.1.0]hexane-2- carboxylic acid tert-butyl ester | C11H18N2O3 | 361440-67-7 | Details |
(1R trans)-2-(3,4-difluorophenyl)cyclopropane aMine | C9H10ClF2N | 1156491-10-9 | Details |
4,6-dichloro-2-(propylthio)pyriMidine | C7H8Cl2N2S | 1401318-10-2 | Details |
(1R,3S,4S)-3-[6-(5,5-DiMethyl-1,3,2-dioxaborinan-2-yl)-1H-benziMidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-diMethylethyl ester | C23H32BN3O4 | 1499193-75-7 | Details |
Tert-butyl (1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexylcarbamate oxalate hydrate | C16H29N3O7 | 1353893-22-7 | Details |
4-AMino-1,1,1-trifluoro-3-buten-2-one | C4H4F3NO | 184848-89-3 | Details |
7-((1R,2R,3R)-2-(4,4-difluoro-3-oxooctyl)-3-hydroxy-5-oxocyclopentyl)heptanoic acid | C20H32F2O5 | 333963-40-9 | Details |
Olean-9(11)-en-28-oic acid, 3,12-dioxo-, methyl ester (9CI) | C31H46O4 | 218600-50-1 | Details |
2-PyrazinecarboxaMide, N-[(1S)-2-[[(1R)-1-hydroxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- | C19H24N4O3 | 289472-78-2 | Details |
Adenosine, N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]- (9CI) | C16H22F3N5O4S2 | 163706-58-9 | Details |
tert-Butyl(1R,2S,5S)-2-({2-[(5-chloropyridin-2-yl)aMino]-2-oxoacetyl}aMino)-5-[(diMethylaMino)carbonyl]cyclohexyl-carbaMate | C21H30ClN5O5 | 480452-36-6 | Details |
(2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol | C13H16F3N5O4S | 163706-51-2 | Details |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid | C23H27NO4 | 1012341-48-8 | Details |
L-Phenylalanine, N-(2-pyrazinylcarbonyl)- | C14H13N3O3 | 114457-94-2 | Details |
Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[[5-aMino-6-chloro-2-(propylthio)-4-pyriMidinyl]aMino]tetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- | C17H27ClN4O4S | 376608-74-1 | Details |
(alphaS)-alpha-[[(1R)-2-Hydroxy-1-phenylethyl]aMino]-tricyclo[3.3.1.1(3,7)]decane-1-acetonitrile | C20H26N2O | 361441-95-4 | Details |
Benzenesulfonic acid, 4-(5-Methyl-3-phenyl-4-isoxazolyl)- | C16H13NO4S | 181696-35-5 | Details |
Ledipasvir acetone solvate | C52H60F2N8O7 | 1441674-54-9 | Details |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)- | C18H25N3O | 361441-98-7 | Details |
2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- | C19H24N4O4 | 886979-81-3 | Details |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- | C18H25N3O2 | 1564265-95-7 | Details |
Phosphonic acid, P,P'-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1) | C13H31Cl2NO6P2 | 163706-61-4 | Details |
Apixaban | C25H25N5O4 | 503612-47-3 | Details |
Ticagrelor | C23H28F2N6O4S | 274693-27-5 | Details |
Tetrahydro-2H-pyran-4-carboxylic acid | C6H10O3 | 5337-03-1 | Details |
(R,R)-1,2-Bis(MethanesulfonyloxyMethyl)cyclohexane ; (1R-trans)-1,2-CyclohexanediMethanol diMethanesulfonate | C10H20O6S2 | 186204-35-3 | Details |
(alphaS)-alpha-[[(1,1-DiMethylethoxy)carbonyl]aMino]-3-hydroxytricyclo [3.3.1.13,7]decane-1-acetic acid | C17H27NO5 | 361442-00-4 | Details |
Isoxazole, 5-Methyl-3,4-diphenyl- (Parecoxib sodiuM inteMediate) | C16H13NO | 37928-17-9 | Details |
5-broMo-4-Methoxy-2-MethylbenzenaMine | C8H10BrNO | 861084-04-0 | Details |
1,2,4]Triazolo[1,5-a]pyriMidine, 7-[3-chloro-5-(trifluoroMethyl)-2-pyridinyl]-5-Methyl- | C12H7ClF3N5 | 1048383-29-4 | Details |
(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol | C14H21N5O5S | 1445580-43-7 | Details |
2-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-(aMinocarbonyl)-, 1,1-diMethylethyl ester, (1R,3S,5R)- | C11H18N2O3 | 1445592-86-8 | Details |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)- | C18H25N3O2 | 1564265-98-0 | Details |
3,4-Dihydro-6,7-dimethoxyisoquinoline hydrochloride | C11H14ClNO2 | 20232-39-7 | Details |
TETRABENAZINE | C19H27NO3 | 58-46-8 | Details |
Eslicarbazepine acetate | C17H16N2O3 | 236395-14-5 | Details |
3-Methyl-1-(3,4-diMethylphenyl)-2-pyrazolin-5-one;2-(3,4-diMethylphenyl)-2,4-dihydro-5-Methyl-3h-pyrazol-3-one | C12H14N2O | 18048-64-1 | Details |
Saxagliptin | C18H25N3O2 | 361442-04-8 | Details |
CANGRELOR | C17H25Cl2F3N5O12P3S2 | 163706-06-7 | Details |
DiMethyl (3,3-difluoro-2-oxoheptyl)phosphonate | C9H17F2O4P | 50889-46-8 | Details |
1-AcetyladaMantane InterMediate | C10H19NO4 | 274693-55-9 | Details |
3-(4-Morpholinyl)-1-(4-nitrophenyl)-5,6-dihydro-2(1H)-pyridinone | C15H17N3O4 | 503615-03-0 | Details |
5,6-Dihydro-3-(4-Morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone | C20H25N3O3 | 545445-44-1 | Details |
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanaMine(S)-(carboxylato(phenyl)Methyl)holMiuM | C17H17F2NO3 | 376608-71-8 | Details |
(S)-N-(1-AMino-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | C14H14N4O2 | 289472-80-6 | Details |
(alphaS)-alpha-[[(1R)-2-Hydroxy-1-phenylethyl]aMino]-tricyclo[3.3.1.1(3,7)]decane-1-acetic acid hydrochloride | C20H28ClNO3 | 361441-96-5 | Details |
(R)-N-Boc-3-HydroxyadaMantylglycine | C17H27NO5 | 1334321-39-9 | Details |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid; | C23H29NO4 | 1012341-50-2 | Details |
(3aR,4S,6R,6aS)-6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-ol | C8H15NO3 | 155899-66-4 | Details |
3-bromo-2-methoxyaniline | C7H8BrNO | 116557-46-1 | Details |
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine,(2R,3R)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid | C34H40N2O8 | 477600-71-8 | Details |
1H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione, hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-, (1aS,4S,6aR,7aS)- | C18H24N2O3 | 1350800-77-9 | Details |
2-PyrazinecarboxaMide, N-[(1S)-2-[[(1R)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- | C19H24N4O4 | 886979-78-8 | Details |
AHU-377 (heMicalciuM salt) | C48H56CaN2O10 | 1369773-39-6 | Details |
Esli Kaxiping Impurity | Details |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)- | C18H25N3O2 | 1564265-96-8 | Details |
3-Chloro-5-(trifluoroMethyl)-2-pyridinecarboxaMide | C7H4ClF3N2O | 338758-69-3 | Details |
(1R,2R)-1,2-CYCLOHEXANEDIMETHANOL | C8H16O2 | 65376-05-8 | Details |
EltroMbopag olaMine | C27H29N5O5 | 496775-62-3 | Details |
Thiazolo[5,4-c]pyridine-2-carboxylic acid, 4,5,6,7-tetrahydro-5-Methyl-, hydrochloride (1:1) | C8H11ClN2O2S | 720720-96-7 | Details |
Ticagrelor iMpurity | C27H45N5O8S | 1882095-51-3 | Details |
3H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one, 6-aMino-1,1a,4,6a,7,7a-hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-, (1aS,4S,6aR,7aS)- | C18H25N3O2 | 1350800-76-8 | Details |
Tricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-diMethylethoxy)carbonyl]aMino]-3,5-dihydroxy-, (αS)- | C17H27NO6 | 681282-72-4 | Details |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- | C18H25N3O2 | 1564265-94-6 | Details |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- | C18H25N3O2 | 1564266-00-7 | Details |
BortezoMib | C19H25BN4O4 | 179324-69-7 | Details |
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | C6H4ClN3 | 3680-69-1 | Details |
2-broMo-4-chloro-6-nitrophenol | C6H3BrClNO3 | 15969-10-5 | Details |
4,6-DICHLORO-5-NITRO-2-PROPYLTHIOPYRIMIDINE | C7H7Cl2N3O2S | 145783-14-8 | Details |
4,6-dichloro-2-propylthiopyriMidine-5-aMine | C7H9Cl2N3S | 145783-15-9 | Details |
Ethyl chloro[(4-Methoxyphenyl)hydrazono]acetate | C11H13ClN2O3 | 27143-07-3 | Details |
2-((3aR,4S,6R,6aS)-6-aMino-2,2-diMethyltetrahydro-3aH-cyclope nta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid | C14H25NO10 | 376608-65-0 | Details |
7-(3-Chloro-5-(trifluoroMethyl)pyridin-2-yl)-5-Methyl-[1,2,4]triazolo[1,5-a]pyriMidine | C12H9ClF3NO2 | 172527-65-0 | Details |
EthanediaMide iMpurity F | C16H22ClN5O3 | 480452-37-7 | Details |
Acetic acid, 2-[[(3aR,4S,6R,6aS)-6-aMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- | C10H17NO5 | 1402150-27-9 | Details |
Product Total: Product Page: | ||||
1 2 3 4 |